Organigram Holdings (OGI) said Friday that it has acquired Motif Labs for upfront consideration of 90 million Canadian dollars ($63.7 million), comprising CA$50 million in cash and CA$40 million of Organigram common shares.
Motif shareholders will also be entitled to get additional contingent consideration of CA$10 million payable in Organigram shares, subject to certain conditions, Organigram said.
The acquisition of Motif makes Organigram the largest cannabis company in Canada by market share, Organigram's chief executive officer, Beena Goldenberg, said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments